GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14052
Submission : 1999-03-18
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15483
Submission : 2001-06-12
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24839
Submission : 2011-04-08
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30290
Submission : 2016-02-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33935
Submission : 2020-08-05
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15027
Submission : 2000-09-07
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27536
Submission : 2013-09-12
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22948
Submission : 2009-07-15
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21597
Submission : 2008-05-07
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21600
Submission : 2008-05-07
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22948
Submission : 2009-07-15
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27536
Submission : 2013-09-12
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15027
Submission : 2000-09-07
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21597
Submission : 2008-05-07
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25349
Submission : 2011-10-17
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21600
Submission : 2008-05-07
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24839
Submission : 2011-04-08
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15483
Submission : 2001-06-12
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30436
Submission : 2016-03-17
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14052
Submission : 1999-03-18
Status : Active
Type : IV
NDC Package Code : 51552-0090
Start Marketing Date : 1998-04-01
End Marketing Date : 2025-04-20
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
FINISHED DOSAGE FORMULATIONS
Drug : AMARYL
Dosage Form : TABLET; ORAL
Application Number : 20496
Country : US
Patented : No
Drug : AMBIEN
Dosage Form : TABLET; ORAL
Application Number : 19908
Country : US
Patented : No
Drug : CLOMID
Dosage Form : TABLET; ORAL
Application Number : 16131
Country : US
Patented : No
Drug : CANTIL
Dosage Form : SOLUTION; ORAL
Application Number : 10679
Country : US
Patented : No
Drug : CANTIL
Dosage Form : TABLET; ORAL
Application Number : 10679
Country : US
Patented : No
Drug : PRIMAQUINE
Dosage Form : TABLET; ORAL
Application Number : 8316
Country : US
Patented : No
Drug : AVAPRO
Dosage Form : TABLET; ORAL
Application Number : 20757
Country : US
Patented : No
Drug : TRIDIONE
Dosage Form : SOLUTION; ORAL
Application Number : 5856
Country : US
Patented : No
Drug : DEPAKOTE ER
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21168
Country : US
Patented : No
Drug : TRIDIONE
Dosage Form : TABLET; ORAL
Application Number : 5856
Country : US
Patented : No
LACTOSE, UNSPECIFIED FORM
Route : BUCCAL
CAS :
UNII : J2B2A4N98G
Potency Amount : 183.3
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : BUCCAL/SUBLINGUAL
CAS :
UNII : J2B2A4N98G
Potency Amount : 296.7
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : IM - IV
CAS :
UNII : J2B2A4N98G
Potency Amount : 20.35
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : IM - IV
CAS :
UNII : J2B2A4N98G
Potency Amount : 0
Potency Unit : NA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : IM - IV - SC
CAS :
UNII : J2B2A4N98G
Potency Amount : 0
Potency Unit : NA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : IM - IV - SC
CAS :
UNII : J2B2A4N98G
Potency Amount : 13.3
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : INHALATION
CAS :
UNII : J2B2A4N98G
Potency Amount : 20
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : INHALATION
CAS :
UNII : J2B2A4N98G
Potency Amount : 25
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : INHALATION
CAS :
UNII : J2B2A4N98G
Potency Amount : 9
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : INTRACAVITARY
CAS :
UNII : J2B2A4N98G
Potency Amount : 19.38
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
Brand Name : Disintequik™ MCC 25
Application : Co-Processed Excipients
Excipient Details : Direct Tabletting Operations Where Fast Disintegration Is Required
Application : Co-Processed Excipients
Excipient Details : Orally Disintegrating Tablets
Application : Co-Processed Excipients
Excipient Details : It is a Co-Processed Lactose starch for filler/binder having strong disintegrant properties.
Application : Granulation
Excipient Details : Ready-to-use direct compression solution for tablets.
Application : Granulation
Excipient Details : Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.
Pharmacopoeia Ref : Ph. Eur., USP/NF and J.P
Technical Specs : Not Available
Ingredient(s) : Lactose
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for tablets.
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.
Pharmacopoeia Ref : Ph. Eur., USP/NF and J.P
Technical Specs : Not Available
Ingredient(s) : Lactose
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Lactose
MARKET PLACE
Reply
31 Aug 2023
Reply
31 May 2023
Reply
16 Feb 2023
Reply
13 Jan 2022
Reply
04 May 2021
Reply
12 Feb 2021
Reply
11 May 2020
LOOKING FOR A SUPPLIER?